Tyrosine	O
phosphorylation	O
is	O
a	O
mandatory	O
proximal	O
step	O
in	O
radiation-induced	O
activation	O
of	O
the	O
protein	B-protein
kinase	I-protein
C	I-protein
signaling	O
pathway	O
in	O
human	B-cell_type
B-lymphocyte	I-cell_type
precursors	I-cell_type
[	O
published	O
erratum	O
appears	O
in	O
Proc	O
Natl	O
Acad	O
Sci	O
U	O
S	O
A	O
1993	O
Apr	O
15	O
;	O
90	O
(	O
8	O
)	O
:	O
3775	O
]	O

Ionizing	O
radiation	O
triggers	O
a	O
signal	O
in	O
human	B-cell_type
B-lymphocyte	I-cell_type
precursors	I-cell_type
that	O
is	O
intimately	O
linked	O
to	O
an	O
active	O
protein-tyrosine	B-protein
kinase	I-protein
regulatory	O
pathway	O
.	O

We	O
show	O
that	O
in	O
B-lymphocyte	B-cell_type
precursors	I-cell_type
,	O
irradiation	O
with	O
gamma-rays	O
leads	O
to	O
(	O
i	O
)	O
stimulation	O
of	O
phosphatidylinositol	O
turnover	O
;	O
(	O
ii	O
)	O
downstream	O
activation	O
by	O
covalent	O
modification	O
of	O
multiple	O
serine-specific	B-protein
protein	I-protein
kinases	I-protein
,	O
including	O
protein	B-protein
kinase	I-protein
C	I-protein
;	O
and	O
(	O
iii	O
)	O
activation	O
of	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
.	O

All	O
of	O
the	O
radiation-induced	O
signals	O
were	O
effectively	O
prevented	O
by	O
the	O
protein-tyrosine	B-protein
kinase	I-protein
inhibitors	I-protein
genistein	I-protein
and	I-protein
herbimycin	I-protein
A	I-protein
.	O

Thus	O
,	O
tyrosine	O
phosphorylation	O
is	O
an	O
important	O
and	O
perhaps	O
mandatory	O
proximal	O
step	O
in	O
the	O
activation	O
of	O
the	O
protein	B-protein
kinase	I-protein
C	I-protein
signaling	O
cascade	O
in	O
human	B-cell_type
B-lymphocyte	I-cell_type
precursors	I-cell_type
.	O

Our	O
report	O
expands	O
current	O
knowledge	O
of	O
the	O
radiation-induced	O
signaling	O
cascade	O
by	O
clarifying	O
the	O
chronological	O
sequence	O
of	O
biochemical	O
events	O
that	O
follow	O
irradiation	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

90	NULL
,	NULL
pp	NULL
.	NULL

252-256	NULL
,	NULL
January	NULL
1993	NULL
Medical	NULL
Sciences	NULL
Tyrosine	NULL
phosphorylation	NULL
is	NULL
a	NULL
mandatory	NULL
proximal	NULL
step	NULL
in	NULL
radiation-induced	NULL
activation	NULL
of	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
signaling	NULL
pathway	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
FatIH	NULL
M.	NULL
Uckun**	NULL
$	NULL
§	NULL
,	NULL
Gary	NULL
L.	NULL
Scuieven	NULL
``	NULL
,	NULL
Lisa	NULL
M.	NULL
TuEL-AKLGREN®*	NULL
,	NULL
ILKER	NULL
DIBIRDIK*	NULL
,	NULL
DoroTtHEA	NULL
E.	NULL
MYyERS*	NULL
,	NULL
JEFFREY	NULL
A	NULL
.	NULL

LEDBETTER	NULL
!	NULL

,	NULL
anp	NULL
CHANG	NULL
W.	NULL
SoncG*	NULL
Sections	NULL
of	NULL
Cancer	NULL
and	NULL
Leukemia	NULL
Biology	NULL
and	NULL
Radiation	NULL
Biology	NULL
,	NULL
Departments	NULL
of	NULL
*Therapeutic	NULL
Radiology-Radiation	NULL
Oncology	NULL
,	NULL
*Pharmacology	NULL
,	NULL
Pediatrics	NULL
,	NULL
and	NULL
the	NULL
$	NULL
Bone	NULL
Marrow	NULL
Transplantation	NULL
Program	NULL
,	NULL
University	NULL
of	NULL
Minnesota	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
55455	NULL
;	NULL
and	NULL
``	NULL
Bristol-Myers	NULL
Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Institute	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98121	NULL
Communicated	NULL
by	NULL
George	NULL
J.	NULL
Todaro	NULL
,	NULL
September	NULL
14	NULL
,	NULL
1992	NULL
(	NULL
received	NULL
for	NULL
review	NULL
April	NULL
12	NULL
,	NULL
1992	NULL
)	NULL
ABSTRACT	NULL
Ionizing	NULL
radiation	NULL
triggers	NULL
a	NULL
signal	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
that	NULL
is	NULL
intimately	NULL
linked	NULL
to	NULL
an	NULL
active	NULL
protein-tyrosine	NULL
kinase	NULL
regulatory	NULL
pathway	NULL
.	NULL

We	NULL
show	NULL
that	NULL
in	NULL
B-lymphocyte	NULL
precursors	NULL
,	NULL
irradiation	NULL
with	NULL
y-rays	NULL
leads	NULL
to	NULL
(	NULL
#	NULL
)	NULL
stimulation	NULL
of	NULL
phosphatidylinositol	NULL
turnover	NULL
;	NULL
(	NULL
#	NULL
)	NULL
downstream	NULL
activation	NULL
by	NULL
covalent	NULL
modification	NULL
of	NULL
multiple	NULL
serine-specific	NULL
protein	NULL
kinases	NULL
,	NULL
including	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
and	NULL
(	NULL
ii	NULL
?	NULL
)	NULL

activation	NULL
of	NULL
nuclear	NULL
factor	NULL
xB	NULL
.	NULL

All	NULL
of	NULL
the	NULL
radiation-induced	NULL
signals	NULL
were	NULL
effectively	NULL
prevented	NULL
by	NULL
the	NULL
protein-tyrosine	NULL
kinase	NULL
inhibitors	NULL
genistein	NULL
and	NULL
herbimycin	NULL
A	NULL
.	NULL

Thus	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
an	NULL
important	NULL
and	NULL
perhaps	NULL
mandatory	NULL
proximal	NULL
step	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
signaling	NULL
cascade	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
.	NULL

Our	NULL
report	NULL
expands	NULL
current	NULL
knowledge	NULL
of	NULL
the	NULL
radiation-induced	NULL
signaling	NULL
cascade	NULL
by	NULL
clarifying	NULL
the	NULL
chronological	NULL
sequence	NULL
of	NULL
biochemical	NULL
events	NULL
that	NULL
follow	NULL
irradiation	NULL
.	NULL

Weichselbaum	NULL
and	NULL
colleagues	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
have	NULL
proposed	NULL
that	NULL
irradiation	NULL
initiates	NULL
a	NULL
cascade	NULL
of	NULL
cytoplasmic	NULL
signaling	NULL
events	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
ionizing	NULL
radiation	NULL
stimulates	NULL
the	NULL
transcription	NULL
of	NULL
immediate	NULL
early	NULL
response	NULL
genes	NULL
that	NULL
encode	NULL
transcriptional	NULL
factors	NULL
,	NULL
by	NULL
activation	NULL
of	NULL
a	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
-dependent	NULL
cytoplasmic	NULL
signaling	NULL
pathway	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
radiation-induced	NULL
signaling	NULL
events	NULL
proximal	NULL
to	NULL
PKC	NULL
activation	NULL
require	NULL
further	NULL
evaluation	NULL
.	NULL

Protein-tyrosine	NULL
kinases	NULL
(	NULL
PTK	NULL
s	NULL
)	NULL
are	NULL
key	NULL
participants	NULL
in	NULL
the	NULL
initiation	NULL
of	NULL
signal	NULL
cascades	NULL
that	NULL
affect	NULL
proliferation	NULL
and	NULL
survival	NULL
of	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
ionizing	NULL
radiation	NULL
stimulates	NULL
several	NULL
PTKs	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
,	NULL
including	NULL
the	NULL
Src	NULL
family	NULL
tyrosine	NULL
kinases	NULL
p599Y®	NULL
and	NULL
p55®	NULL
``	NULL
*	NULL
,	NULL
leading	NULL
to	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
substrates	NULL
and	NULL
triggering	NULL
apoptosis	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Since	NULL
PTKs	NULL
play	NULL
myriad	NULL
roles	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
function	NULL
and	NULL
proliferation	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
PTK	NULL
cascade	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
may	NULL
explain	NULL
the	NULL
pleiotropic	NULL
effects	NULL
of	NULL
ionizing	NULL
radiation	NULL
on	NULL
cellular	NULL
functions	NULL
.	NULL

The	NULL
present	NULL
study	NULL
expands	NULL
earlier	NULL
work	NULL
by	NULL
specifically	NULL
examining	NULL
the	NULL
role	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
radiation-induced	NULL
activation	NULL
of	NULL
the	NULL
PKC	NULL
pathway	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
at	NULL
discrete	NULL
developmental	NULL
stages	NULL
of	NULL
B-cell	NULL
ontogeny	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
herbimycin	NULL
and	NULL
genistein	NULL
effectively	NULL
inhibited	NULL
radiation-induced	NULL
activation	NULL
of	NULL
PKC	NULL
(	NULL
PK76	NULL
)	NULL
and	NULL
PKC-dependent	NULL
serine	NULL
kinases	NULL
PK	NULL
55	NULL
and	NULL
PK50	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
kB	NULL
(	NULL
NF-KB	NULL
)	NULL
in	NULL
irradiated	NULL
B-lymphocyte	NULL
precursors	NULL
was	NULL
abrogated	NULL
by	NULL
pretreatment	NULL
with	NULL
herbimycin	NULL
or	NULL
genistein	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
radiation-induced	NULL
activation	NULL
of	NULL
the	NULL
PKC	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

252	NULL
signaling	NULL
cascade	NULL
leads	NULL
to	NULL
downstream	NULL
activation	NULL
of	NULL
multiple	NULL
serine-specific	NULL
protein	NULL
kinases	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
evidence	NULL
provided	NULL
reveals	NULL
that	NULL
these	NULL
events	NULL
are	NULL
triggered	NULL
by	NULL
radiation-induced	NULL
stimulation	NULL
of	NULL
tyrosine-specific	NULL
protein	NULL
ki-nases	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Patient	NULL
Material	NULL
and	NULL
Cell	NULL
Lines	NULL
.	NULL

We	NULL
used	NULL
the	NULL
CD19+CD10+	NULL
C	NULL
,	NULL
sIgM-	NULL
pre-pre-B	NULL
cell	NULL
line	NULL
REH	NULL
,	NULL
the	NULL
CD19+CD10*	NULL
C	NULL
sigM-	NULL
pre-B	NULL
cell	NULL
line	NULL
NALM-6	NULL
,	NULL
and	NULL
the	NULL
CD19+CD10-C	NULL
,	NULL
;	NULL
sigM*	NULL
early	NULL
B/Burkitt	NULL
lymphoma	NULL
cell	NULL
lines	NULL
Daudi	NULL
and	NULL
Ramos	NULL
.	NULL

The	NULL
immunophenotypic	NULL
and	NULL
genotypic	NULL
features	NULL
and	NULL
the	NULL
radiation	NULL
sensitivity	NULL
of	NULL
these	NULL
human	NULL
B-lymphocyte	NULL
precursor	NULL
cell	NULL
lines	NULL
were	NULL
detailed	NULL
in	NULL
a	NULL
previous	NULL
report	NULL
(	NULL
8	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
undergo	NULL
apoptosis	NULL
within	NULL
24	NULL
hr	NULL
after	NULL
exposure	NULL
to	NULL
2-4	NULL
Gy	NULL
of	NULL
y-rays	NULL
(	NULL
5	NULL
,	NULL
8	NULL
)	NULL
.	NULL

We	NULL
also	NULL
used	NULL
primary	NULL
bone	NULL
marrow	NULL
blasts	NULL
from	NULL
a	NULL
pre-pre-B	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
patient	NULL
(	NULL
UPN	NULL
10	NULL
)	NULL
,	NULL
following	NULL
the	NULL
guidelines	NULL
of	NULL
the	NULL
University	NULL
of	NULL
Minnesota	NULL
Committee	NULL
on	NULL
the	NULL
Use	NULL
of	NULL
Human	NULL
Subjects	NULL
in	NULL
Research	NULL
for	NULL
secondary	NULL
use	NULL
of	NULL
pathologic	NULL
or	NULL
surgical	NULL
tissue	NULL
.	NULL

Irradiation	NULL
of	NULL
Cells	NULL
and	NULL
the	NULL
Use	NULL
of	NULL
Kinase	NULL
Inhibitors	NULL
.	NULL

Cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
per	NULL
ml	NULL
in	NULL
plastic	NULL
tissue	NULL
culture	NULL
flasks	NULL
)	NULL
were	NULL
irradiated	NULL
during	NULL
a	NULL
logarithmic	NULL
growth	NULL
phase	NULL
and	NULL
under	NULL
aerobic	NULL
conditions	NULL
with	NULL
a	NULL
``	NULL
Cs	NULL
irradiator	NULL
(	NULL
J.	NULL
L.	NULL
Shephard	NULL
and	NULL
Assoc	NULL
.	NULL

,	NULL
Glendale	NULL
,	NULL
CA	NULL
,	NULL
model	NULL
mark	NULL
I	NULL
)	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

For	NULL
the	NULL
inositol	NULL
1,4,5-trisphosphate	NULL
(	NULL
Ins-1,4,5-P	NULL
;	NULL
3	NULL
)	NULL
assays	NULL
and	NULL
the	NULL
serine	NULL
kinase	NULL
renaturation	NULL
assays	NULL
,	NULL
cells	NULL
were	NULL
irradiated	NULL
with	NULL
100-400	NULL
cGy	NULL
at	NULL
a	NULL
dose	NULL
rate	NULL
of	NULL
99	NULL
cGy/min	NULL
.	NULL

In	NULL
analyses	NULL
of	NULL
radiation-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
cells	NULL
were	NULL
irradiated	NULL
with	NULL
1000-4000	NULL
cGy	NULL
at	NULL
a	NULL
dose	NULL
rate	NULL
of	NULL
326	NULL
cGy/min	NULL
.	NULL

Prior	NULL
to	NULL
irradiation	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°C	NULL
with	NULL
(	NULL
a	NULL
)	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
(	NULL
b	NULL
)	NULL
the	NULL
PTK	NULL
inhibitor	NULL
genistein	NULL
(	NULL
100	NULL
ug/ml	NULL
=	NULL
370	NULL
uM	NULL
;	NULL
ICN	NULL
)	NULL
,	NULL
or	NULL
(	NULL
c	NULL
)	NULL
the	NULL
PKC	NULL
inhibitor	NULL
1-	NULL
(	NULL
5-isoquinolinylsulfonyl	NULL
)	NULL
-2-methylpiperazine	NULL
(	NULL
H7	NULL
,	NULL
11	NULL
ug/ml	NULL
=	NULL
30	NULL
uM	NULL
;	NULL
GIBCO/BRL	NULL
)	NULL
,	NULL
or	NULL
(	NULL
d	NULL
)	NULL
for	NULL
24	NULL
hr	NULL
at	NULL
37°C	NULL
with	NULL
the	NULL
benzoquinoid	NULL
ansamycin	NULL
antibiotic	NULL
herbimycin	NULL
A	NULL
(	NULL
7	NULL
pg/ml	NULL
=	NULL
12	NULL
uM	NULL
;	NULL
Sigma	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
potent	NULL
PTK	NULL
inhibitor	NULL
,	NULL
according	NULL
to	NULL
published	NULL
protocols	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

At	NULL
the	NULL
applied	NULL
concentrations	NULL
,	NULL
these	NULL
compounds	NULL
effectively	NULL
inhibit	NULL
their	NULL
target	NULL
enzymes	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Genistein	NULL
competes	NULL
with	NULL
the	NULL
ATP	NULL
binding	NULL
site	NULL
of	NULL
PTK	NULL
s	NULL
and	NULL
inhibits	NULL
their	NULL
activation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
herbimycin	NULL
is	NULL
not	NULL
a	NULL
classic	NULL
competitive	NULL
inhibitor	NULL
of	NULL
PTKs	NULL
but	NULL
rather	NULL
targets	NULL
PTKs	NULL
for	NULL
degradation	NULL
and	NULL
leads	NULL
to	NULL
actual	NULL
loss	NULL
of	NULL
these	NULL
proteins	NULL
.	NULL

In	NULL
general	NULL
,	NULL
herbimycin	NULL
is	NULL
a	NULL
more	NULL
potent	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
in	NULL
B-lineage	NULL
lymphoid	NULL
cells	NULL
.	NULL

Whereas	NULL
genistein	NULL
usually	NULL
attenuates	NULL
tyrosine	NULL
kinase-linked	NULL
signals	NULL
,	NULL
herbimycin	NULL
abolishes	NULL
them	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
Abbreviations	NULL
:	NULL
Ins-1,4,5-P	NULL
;	NULL
,	NULL
inositol	NULL
1,4,5-trisphosphate	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
;	NULL
PAP	NULL
,	NULL
pokeweed	NULL
antiviral	NULL
protein	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
PLC	NULL
,	NULL
phospholipase	NULL
C	NULL
;	NULL
PtdIns	NULL
,	NULL
phosphatidylinosito	NULL
!	NULL

;	NULL
PTK	NULL
,	NULL
protein-tyrosine	NULL
kinase	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Uckun	NULL
et	NULL
al	NULL
.	NULL

cells	NULL
were	NULL
pretreated	NULL
with	NULL
B43	NULL
(	NULL
anti-CD19	NULL
)	NULL
-pokeweed	NULL
antiviral	NULL
protein	NULL
(	NULL
PAP	NULL
)	NULL
immunotoxin	NULL
(	NULL
10	NULL
)	NULL
or	NULL
mafosfamid	NULL
prior	NULL
to	NULL
radiation	NULL
exposure	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
B43-PAP	NULL
immunotoxin	NULL
for	NULL
16	NULL
hr	NULL
at	NULL
37°C	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
B43-PAP	NULL
kills	NULL
>	NULL
99.9	NULL
%	NULL
of	NULL
human	NULL
B-cell	NULL
precursors	NULL
by	NULL
an	NULL
irreversible	NULL
inhibition	NULL
of	NULL
ribosomal	NULL
protein	NULL
synthesis	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Mafosfamid	NULL
(	NULL
ASTA	NULL
Werke	NULL
,	NULL
Bielefeld	NULL
,	NULL
Germany	NULL
)	NULL
is	NULL
an	NULL
in	NULL
vitro-active	NULL
congener	NULL
of	NULL
the	NULL
oxazaphosphorine	NULL
cyclophosphamide	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
mafosfamid	NULL
(	NULL
50	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
mafosfamid	NULL
kills	NULL
>	NULL
99.9	NULL
%	NULL
of	NULL
human	NULL
B-cell	NULL
precursors	NULL
by	NULL
DNA	NULL
alkylation	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Measurement	NULL
of	NULL
Ins-1,4,5-P	NULL
;	NULL
Levels	NULL
.	NULL

After	NULL
irradiation	NULL
,	NULL
Ins-1,4,5-P	NULL
;	NULL
levels	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
were	NULL
measured	NULL
with	NULL
a	NULL
highly	NULL
specific	NULL
o-myo-	NULL
[	NULL
'	NULL
H	NULL
]	NULL
Ins-1,4,5-P	NULL
;	NULL
assay	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
,	NULL
as	NULL
described	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

This	NULL
assay	NULL
is	NULL
based	NULL
on	NULL
the	NULL
competition	NULL
between	NULL
unlabeled	NULL
Ins-1,4,5-P	NULL
;	NULL
and	NULL
a	NULL
fixed	NULL
quantity	NULL
of	NULL
a	NULL
high-specific-activity	NULL
[	NULL
*H	NULL
)	NULL
iIns-1,4,5-P	NULL
;	NULL
tracer	NULL
for	NULL
a	NULL
limited	NULL
number	NULL
of	NULL
binding	NULL
sites	NULL
on	NULL
a	NULL
specific	NULL
and	NULL
sensitive	NULL
bovine	NULL
adrenal	NULL
binding-protein	NULL
preparation	NULL
.	NULL

Renaturation	NULL
Assay	NULL
for	NULL
Analysis	NULL
of	NULL
Protein-Serine	NULL
Kinase	NULL
Activation	NULL
.	NULL

We	NULL
used	NULL
the	NULL
kinase	NULL
renaturation	NULL
method	NULL
of	NULL
Ferrell	NULL
and	NULL
Martin	NULL
(	NULL
11	NULL
)	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
ionizing	NULL
radiation	NULL
on	NULL
the	NULL
activities	NULL
of	NULL
renaturable	NULL
serine/threonine-specific	NULL
protein	NULL
kinases	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursor	NULL
cells	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
kinase	NULL
renaturation	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
immunoprecipitated	NULL
PKC	NULL
as	NULL
follows	NULL
.	NULL

Irradiated	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
immunoprecipitation	NULL
buffer	NULL
[	NULL
150	NULL
mM	NULL
NaCl/50	NULL
mM	NULL
Tris	NULL
CJ	NULL
,	NULL
pH	NULL
7.5/1	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
Nonidet	NULL
P-40/1	NULL
mM	NULL
Na	NULL
;	NULL
VO,4	NULL
,	NULL
/1	NULL
mM	NULL
sodium	NULL
molyb-date	NULL
]	NULL
containing	NULL
phenylImethanesulfonyl	NULL
fluoride	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
,	NULL
leupeptin	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
aprotinin	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

Nuclei	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
of	NULL
PKC	NULL
with	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
anti-pan	NULL
PKC	NULL
antibody	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
which	NULL
was	NULL
generated	NULL
by	NULL
using	NULL
a	NULL
synthetic	NULL
peptide	NULL
corresponding	NULL
to	NULL
C-terminal	NULL
sequences	NULL
of	NULL
rabbit	NULL
protein	NULL
kinase	NULL
type	NULL
BII	NULL
as	NULL
immunogen	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
anti-PKC	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
5	NULL
ug/ml	NULL
)	NULL
for	NULL
1.5	NULL
hr	NULL
at	NULL
0°C	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
lysates	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
4°C	NULL
to	NULL
recover	NULL
the	NULL
immune	NULL
complexes	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
washed	NULL
six	NULL
times	NULL
in	NULL
immunoprecipitation	NULL
buffer	NULL
and	NULL
then	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
in	NULL
2x	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

Samples	NULL
were	NULL
run	NULL
in	NULL
SDS/polyacryl-amide	NULL
gels	NULL
and	NULL
subsequently	NULL
immunoblotted	NULL
with	NULL
anti-PKC	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

**5I-labeled	NULL
protein	NULL
A	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
PKC	NULL
.	NULL

Kinase	NULL
renaturation	NULL
assays	NULL
on	NULL
the	NULL
anti-PKC	NULL
immunoprecipitates	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
for	NULL
whole	NULL
cell	NULL
lysates	NULL
.	NULL

Nuclear	NULL
Extraction	NULL
and	NULL
Electrophoretic	NULL
Mobility-Shift	NULL
As-says	NULL
.	NULL

After	NULL
irradiation	NULL
of	NULL
cells	NULL
,	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
according	NULL
to	NULL
published	NULL
procedures	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Aliquots	NULL
(	NULL
50	NULL
ng	NULL
)	NULL
of	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
tandem	NULL
repeat	NULL
of	NULL
the	NULL
11-base-pair	NULL
consensus	NULL
sequence	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
site	NULL
(	NULL
GGGGACTTTCC	NULL
)	NULL
,	NULL
which	NULL
was	NULL
obtained	NULL
in	NULL
kit	NULL
form	NULL
from	NULL
GIBCO/BRL	NULL
,	NULL
were	NULL
end-labeled	NULL
by	NULL
using	NULL
[	NULL
y-	NULL
>	NULL
P	NULL
]	NULL
JATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
according	NULL
to	NULL
the	NULL
recommendations	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

One	NULL
nanogram	NULL
of	NULL
the	NULL
radiolabeled	NULL
oligonucleotide	NULL
(	NULL
400,000	NULL
cpm	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
12	NULL
wl	NULL
of	NULL
25	NULL
mM	NULL
Tris	NULL
Cl	NULL
,	NULL
pH	NULL
7.6/5	NULL
mM	NULL
MgCl	NULL
;	NULL
/0.5	NULL
mM	NULL
EDTA/1	NULL
mM	NULL
dithiothreitol	NULL
/10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
containing	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Competition	NULL
studies	NULL
were	NULL
performed	NULL
by	NULL
preincubating	NULL
the	NULL
nuclear	NULL
protein	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
with	NULL
a	NULL
500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
*°P-end-labeled	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
.	NULL

Controls	NULL
used	NULL
S500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
AP-1	NULL
and	NULL
NF-1	NULL
oligonucleotide	NULL
probes	NULL
for	NULL
competition	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
in	NULL
the	NULL
reaction	NULL
mixture	NULL
were	NULL
ana	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
253	NULL
lyzed	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
using	NULL
a	NULL
4.5	NULL
%	NULL
running	NULL
gel	NULL
under	NULL
nondenaturing	NULL
conditions	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
Tris	NULL
base/22.5	NULL
mM	NULL
boric	NULL
acid/0.25	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
8.2	NULL
)	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
pre-run	NULL
at	NULL
150	NULL
V	NULL
for	NULL
2	NULL
hr	NULL
at	NULL
4°C	NULL
before	NULL
the	NULL
samples	NULL
were	NULL
loaded	NULL
and	NULL
electrophoresed	NULL
for	NULL
an	NULL
additional	NULL
3	NULL
hr	NULL
at	NULL
150	NULL
V.	NULL
Gels	NULL
were	NULL
dried	NULL
overnight	NULL
and	NULL
exposed	NULL
at	NULL
-70°C	NULL
to	NULL
Kodak	NULL
XAR-5	NULL
x-ray	NULL
film	NULL
with	NULL
intensi-	NULL
fying	NULL
screens	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Role	NULL
of	NULL
Tyrosine	NULL
Phosphorylation	NULL
in	NULL
Radiation-Induced	NULL
Stimulation	NULL
of	NULL
Phosphatidylinositol	NULL
(	NULL
PtdIns	NULL
)	NULL
Turnover	NULL
in	NULL
Human	NULL
B-Lymphocyte	NULL
Precursors	NULL
.	NULL

Previous	NULL
studies	NULL
by	NULL
Weichselbaum	NULL
and	NULL
colleagues	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
provided	NULL
elegant	NULL
,	NULL
albeit	NULL
cir-cumstantial	NULL
,	NULL
evidence	NULL
that	NULL
ionizing	NULL
radiation	NULL
triggers	NULL
PKC	NULL
activation	NULL
.	NULL

PKC	NULL
is	NULL
an	NULL
enzyme	NULL
that	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
transduction	NULL
of	NULL
growth-regulatory	NULL
signals	NULL
.	NULL

Its	NULL
activation	NULL
under	NULL
physiologic	NULL
conditions	NULL
is	NULL
mediated	NULL
by	NULL
stimulation	NULL
of	NULL
PitdIns-specific	NULL
phospholipase	NULL
C-y	NULL
(	NULL
PLC-y	NULL
)	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Ionizing	NULL
radiation	NULL
causes	NULL
radiolysis	NULL
of	NULL
bound	NULL
and	NULL
solvent	NULL
water	NULL
in	NULL
the	NULL
cell	NULL
,	NULL
producing	NULL
hydroxyl	NULL
radicals	NULL
,	NULL
superoxide	NULL
radicals	NULL
,	NULL
and	NULL
hydrogen	NULL
peroxide	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Oxidants	NULL
such	NULL
as	NULL
hydrogen	NULL
peroxide	NULL
and	NULL
superoxide	NULL
can	NULL
induce	NULL
activation	NULL
of	NULL
PLC-y	NULL
,	NULL
leading	NULL
to	NULL
Ca®+	NULL
mobilization	NULL
and	NULL
PKC	NULL
activation	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
catalytic	NULL
activity	NULL
of	NULL
PLC-y	NULL
is	NULL
regulated	NULL
through	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
receptor-	NULL
and	NULL
non-receptor-type	NULL
PTKs	NULL
(	NULL
4	NULL
,	NULL
20	NULL
,	NULL
21	NULL
)	NULL
,	NULL
and	NULL
biochemical	NULL
signals	NULL
that	NULL
trigger	NULL
tyrosine-specific	NULL
protein	NULL
phosphorylation	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
precede	NULL
the	NULL
activation	NULL
of	NULL
PLC-y	NULL
and	NULL
stimulation	NULL
of	NULL
PtdIns	NULL
turnover	NULL
in	NULL
many	NULL
experimental	NULL
systems	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
prompted	NULL
us	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
ionizing	NULL
radiation	NULL
on	NULL
inositolphospholipid	NULL
turnover	NULL
in	NULL
human	NULL
lymphocyte	NULL
precursors	NULL
.	NULL

For	NULL
this	NULL
,	NULL
we	NULL
used	NULL
a	NULL
highly	NULL
specific	NULL
and	NULL
quantitative	NULL
p-myo-	NULL
[	NULL
}	NULL
HlIns-1,4,5-P	NULL
;	NULL
assay	NULL
system	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Ionizing	NULL
radiation	NULL
stimulated	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
production	NULL
of	NULL
Ins-1,4,5-P	NULL
;	NULL
by	NULL
FL112	NULL
pro-B	NULL
,	NULL
REH	NULL
pre-pre-B	NULL
,	NULL
NALM-6	NULL
pre-B	NULL
,	NULL
and	NULL
Daudi	NULL
early	NULL
B	NULL
cells	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
treatment	NULL
of	NULL
these	NULL
human	NULL
B-lymphocyte	NULL
precursor	NULL
cell	NULL
lines	NULL
with	NULL
B43	NULL
(	NULL
anti-CD19	NULL
)	NULL
-PAP	NULL
immunotoxin	NULL
,	NULL
which	NULL
kills	NULL
target	NULL
cells	NULL
by	NULL
an	NULL
irreversible	NULL
inhibition	NULL
of	NULL
ribosomal	NULL
protein	NULL
synthesis	NULL
(	NULL
10	NULL
)	NULL
,	NULL
or	NULL
with	NULL
the	NULL
in	NULL
vitro-active	NULL
cyclophosphamide	NULL
congener	NULL
mafosfamid	NULL
,	NULL
which	NULL
kills	NULL
target	NULL
cells	NULL
by	NULL
DNA	NULL
alkylation	NULL
(	NULL
10	NULL
)	NULL
,	NULL
did	NULL
not	NULL
stimulate	NULL
PtdIns	NULL
turnover	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
kinetics	NULL
of	NULL
radiation-induced	NULL
PtdIns	NULL
turnover	NULL
.	NULL

Irradiation	NULL
of	NULL
REH	NULL
pre-pre-B	NULL
cells	NULL
and	NULL
Daudi	NULL
early	NULL
B	NULL
cells	NULL
with	NULL
200	NULL
cGy	NULL
of	NULL
y-rays	NULL
stimulated	NULL
a	NULL
rapid	NULL
and	NULL
monophasic	NULL
increase	NULL
in	NULL
the	NULL
production	NULL
of	NULL
Ins-1,4,5-P	NULL
;	NULL
leading	NULL
to	NULL
markedly	NULL
elevated	NULL
Ins-1,4,5-P	NULL
;	NULL
levels	NULL
between	NULL
30	NULL
sec	NULL
and	NULL
3	NULL
min	NULL
after	NULL
completion	NULL
of	NULL
radiation	NULL
exposure	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
2.5	NULL
min	NULL
and	NULL
5	NULL
min	NULL
after	NULL
the	NULL
start	NULL
of	NULL
radiation	NULL
exposure	NULL
at	NULL
a	NULL
dose	NULL
rate	NULL
of	NULL
99	NULL
cGy/min	NULL
)	NULL
.	NULL

Thereafter	NULL
,	NULL
the	NULL
level	NULL
of	NULL
Ins-1,4,5-P	NULL
;	NULL
rapidly	NULL
declined	NULL
but	NULL
at	NULL
5	NULL
min	NULL
it	NULL
was	NULL
still	NULL
higher	NULL
than	NULL
the	NULL
baseline	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
experiments	NULL
provide	NULL
conclusive	NULL
evidence	NULL
that	NULL
the	NULL
biochemical	NULL
signal	NULL
triggered	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
by	NULL
ionizing	NULL
radiation	NULL
is	NULL
intimately	NULL
linked	NULL
to	NULL
signal-transduction	NULL
pathways	NULL
that	NULL
stimulate	NULL
inositolphospholipid	NULL
turnover	NULL
,	NULL
producing	NULL
Ins-1,4,5-P	NULL
;	NULL
as	NULL
a	NULL
second	NULL
messenger	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
PTK	NULL
inhibitors	NULL
genistein	NULL
and	NULL
herbimycin	NULL
effectively	NULL
prevented	NULL
the	NULL
radiation-triggered	NULL
Ins-1,4,5-P	NULL
;	NULL
signals	NULL
,	NULL
whereas	NULL
H7	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
PKC	NULL
and	NULL
PKC-dependent	NULL
serine/threonine	NULL
kinases	NULL
,	NULL
did	NULL
not	NULL
.	NULL

These	NULL
observations	NULL
provide	NULL
strong	NULL
evidence	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
a	NULL
requisite	NULL
step	NULL
in	NULL
the	NULL
radiation-triggered	NULL
stimulation	NULL
of	NULL
PtdIns	NULL
turnover	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
.	NULL

Role	NULL
of	NULL
Tyrosine	NULL
Phosphorylation	NULL
in	NULL
Radiation-Induced	NULL
Activation	NULL
of	NULL
PKC	NULL
and	NULL
PKC-Dependent	NULL
Renaturable	NULL
Serine	NULL
Kinases	NULL
in	NULL
Human	NULL
B-Lymphocyte	NULL
Precursors	NULL
.	NULL

Using	NULL
the	NULL
kinase	NULL
renaturation	NULL
method	NULL
of	NULL
Ferrell	NULL
and	NULL
Martin	NULL
(	NULL
11	NULL
)	NULL
,	NULL
we	NULL
previously	NULL
254	NULL
Medical	NULL
Sciences	NULL
:	NULL
Uckun	NULL
et	NULL
al	NULL
.	NULL

REH	NULL
so	NULL
so	NULL
40	NULL
sam	NULL
&	NULL
8	NULL
*	NULL
_	NULL
yrays	NULL
t	NULL
Mafostamid	NULL
R	NULL
Ass	NULL
B43-PAP	NULL
E	NULL
06	NULL
155	NULL
30	NULL
``	NULL
9s	NULL
3	NULL
5	NULL
h	NULL
~d	NULL
a	NULL
?	NULL

80-w	NULL
hl	NULL
v2	NULL
607	NULL
&	NULL
£	NULL
40—	NULL
y-rays	NULL
+	NULL
H7	NULL
{	NULL
4	NULL
/	NULL
20	NULL
Z	NULL
yrays	NULL
/-Huyu+HERB	NULL
~	NULL
pas	NULL
o	NULL
<	NULL
o	NULL
G5	NULL
30°	NULL
4°	NULL
3	NULL
%	NULL
5	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
DAUDI	NULL
w	NULL
m	NULL
4°	NULL
207	NULL
-	NULL
Y1ay	NULL
$	NULL
PBs	NULL
o	NULL
__/	NULL
0	NULL
``	NULL
15	NULL
``	NULL
30	NULL
%	NULL
45	NULL
3°	NULL
O5	NULL
m	NULL
w	NULL
40-yrays	NULL
20	NULL
rays	NULL
+	NULL
H7	NULL
/1-rnys+HER8	NULL
\1-mys+GEN	NULL
0	NULL
o	NULL
'	NULL
45	NULL
``	NULL
30	NULL
``	NULL
a	NULL
'	NULL
3	NULL
-	NULL
g	NULL
PBS	NULL
Time	NULL
After	NULL
Treatment	NULL
Fig	NULL
.	NULL

1.	NULL
.	NULL

Magnitude	NULL
and	NULL
kinetics	NULL
of	NULL
radiation-stimulated	NULL
PtdIns	NULL
turnover	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
.	NULL

REH	NULL
pre-pre-B	NULL
and	NULL
Daudi	NULL
early	NULL
B	NULL
cells	NULL
were	NULL
irradiated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
PTK	NULL
inhibitors	NULL
genistein	NULL
(	NULL
GEN	NULL
)	NULL
or	NULL
herbimycin	NULL
A	NULL
(	NULL
HERB	NULL
)	NULL
or	NULL
the	NULL
PKC	NULL
inhibitor	NULL
H7	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
Ins-1,4,5-P	NULL
;	NULL
levels	NULL
were	NULL
determined	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
{	NULL
15	NULL
sec	NULL
(	NULL
15	NULL
``	NULL
)	NULL
to	NULL
5	NULL
min	NULL
(	NULL
5	NULL
'	NULL
)	NULL
]	NULL
by	NULL
using	NULL
a	NULL
highly	NULL
specific	NULL
assay	NULL
system	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

The	NULL
Ins-1,4,5-P	NULL
;	NULL
responses	NULL
were	NULL
analyzed	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
quadruplicate	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
pmol	NULL
amounts	NULL
of	NULL
Ins-1,4,5-P	NULL
;	NULL
per	NULL
10°	NULL
cells	NULL
.	NULL

Control	NULL
samples	NULL
were	NULL
treated	NULL
with	NULL
phosphate	NULL
buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
mafosfamid	NULL
,	NULL
or	NULL
B43-PAP	NULL
immunotoxin	NULL
.	NULL

found	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
PLC/PKC	NULL
cascade	NULL
in	NULL
human	NULL
B-cell	NULL
precursors	NULL
by	NULL
phorbol	NULL
ester	NULL
plus	NULL
ionomycin	NULL
or	NULL
antibodies	NULL
directed	NULL
against	NULL
sIgM	NULL
,	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
,	NULL
and	NULL
CD40	NULL
antigens	NULL
enhanced	NULL
the	NULL
activity	NULL
of	NULL
multiple	NULL
serine/threonine	NULL
kinases	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
renaturable	NULL
kinase	NULL
activity	NULL
toward	NULL
the	NULL
blocking	NULL
protein	NULL
substrate	NULL
albumin	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
PLC/PKC	NULL
cascade	NULL
in	NULL
irradiated	NULL
B-lymphocyte	NULL
precursors	NULL
prompted	NULL
us	NULL
to	NULL
use	NULL
this	NULL
kinase	NULL
renaturation	NULL
method	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
ionizing	NULL
radiation	NULL
on	NULL
the	NULL
activities	NULL
of	NULL
serine-specific	NULL
protein	NULL
kinases	NULL
in	NULL
target	NULL
cell	NULL
populations	NULL
.	NULL

Irradiation	NULL
of	NULL
Ramos	NULL
early	NULL
B	NULL
cells	NULL
and	NULL
REH	NULL
pre-pre-B	NULL
cells	NULL
enhanced	NULL
within	NULL
15	NULL
min	NULL
the	NULL
in	NULL
vitro	NULL
activity	NULL
of	NULL
three	NULL
renaturable	NULL
serine/threonine-specific	NULL
protein	NULL
kinases	NULL
of	NULL
apparent	NULL
molecular	NULL
masses	NULL
of	NULL
76	NULL
kDa	NULL
(	NULL
PK76	NULL
)	NULL
,	NULL
55	NULL
kDa	NULL
(	NULL
PK	NULL
55	NULL
)	NULL
,	NULL
and	NULL
50	NULL
kDa	NULL
(	NULL
PK50	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Phospho	NULL
amino	NULL
acid	NULL
analysis	NULL
of	NULL
the	NULL
kinase	NULL
bands	NULL
by	NULL
two-dimensional	NULL
thin-layer	NULL
electrophoresis	NULL
demonstrated	NULL
that	NULL
these	NULL
renaturable	NULL
kinases	NULL
phosphorylate	NULL
only	NULL
serine	NULL
residues	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
Daudi	NULL
early	NULL
B	NULL
cells	NULL
,	NULL
ionizing	NULL
radiation	NULL
stimulated	NULL
PK76	NULL
and	NULL
PK55	NULL
,	NULL
while	NULL
in	NULL
UPN10	NULL
pre-pre-B	NULL
cells	NULL
,	NULL
only	NULL
PK76	NULL
showed	NULL
enhanced	NULL
activity	NULL
after	NULL
radiation	NULL
exposure	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
PKS5S5	NULL
and	NULL
PKS50	NULL
are	NULL
PKC-dependent	NULL
serine	NULL
kinases	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
the	NULL
renaturable	NULL
serine/threonine	NULL
kinase	NULL
PK76	NULL
was	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
PKC	NULL
(	NULL
77	NULL
kDa	NULL
)	NULL
,	NULL
we	NULL
postulated	NULL
that	NULL
PK76	NULL
may	NULL
indeed	NULL
be	NULL
PKC	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
immunoprecipitated	NULL
PKC	NULL
from	NULL
whole	NULL
cell	NULL
lysates	NULL
of	NULL
unirradiated	NULL
and	NULL
irradiated	NULL
Ramos	NULL
cells	NULL
with	NULL
an	NULL
anti-PKC	NULL
antibody	NULL
and	NULL
examined	NULL
its	NULL
activity	NULL
by	NULL
the	NULL
kinase	NULL
renaturation	NULL
assay	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
PKC	NULL
were	NULL
immunoprecipitated	NULL
from	NULL
unirradiated	NULL
as	NULL
well	NULL
as	NULL
irradiated	NULL
cells	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
PKC	NULL
immunoprecipitates	NULL
with	NULL
the	NULL
same	NULL
anti-PKC	NULL
antibody	NULL
that	NULL
was	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
.	NULL

PKC	NULL
that	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
the	NULL
lysates	NULL
of	NULL
irradiated	NULL
cells	NULL
showed	NULL
enhanced	NULL
renaturable	NULL
kinase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
corroborate	NULL
and	NULL
extend	NULL
the	NULL
findings	NULL
of	NULL
Weichselbaum	NULL
and	NULL
colleagues	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
and	NULL
provide	NULL
direct	NULL
evidence	NULL
that	NULL
ionizing	NULL
radiation	NULL
stimulates	NULL
PKC	NULL
.	NULL

The	NULL
increased	NULL
renaturable	NULL
kinase	NULL
activity	NULL
of	NULL
PKC	NULL
most	NULL
likely	NULL
results	NULL
from	NULL
covalent	NULL
modification	NULL
,	NULL
since	NULL
any	NULL
stimulatory	NULL
factors	NULL
(	NULL
such	NULL
as	NULL
diacylglycerol	NULL
)	NULL
would	NULL
be	NULL
separated	NULL
from	NULL
the	NULL
PKC	NULL
protein	NULL
by	NULL
denaturation	NULL
in	NULL
SDS	NULL
,	NULL
subsequent	NULL
gel	NULL
electropho-resis	NULL
,	NULL
and	NULL
blotting	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
PTK	NULL
inhibitors	NULL
genistein	NULL
and	NULL
herbimycin	NULL
effectively	NULL
prevented	NULL
the	NULL
radiation-induced	NULL
stimulation	NULL
of	NULL
PK76	NULL
,	NULL
PK55	NULL
,	NULL
and	NULL
PK	NULL
50	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
at	NULL
concentrations	NULL
that	NULL
inhibited	NULL
radiation-induced	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Renaturation	NULL
assays	NULL
of	NULL
the	NULL
kinase	NULL
activity	NULL
in	NULL
anti-PKC	NULL
immunoprecipitates	NULL
from	NULL
unirradiated	NULL
and	NULL
irradiated	NULL
Ramos	NULL
cells	NULL
showed	NULL
that	NULL
herbimycin	NULL
could	NULL
prevent	NULL
the	NULL
stimulation	NULL
of	NULL
PKC	NULL
after	NULL
ionizing	NULL
radiation	NULL
more	NULL
effectively	NULL
than	NULL
the	NULL
potent	NULL
PKC	NULL
inhibitor	NULL
H7	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
provide	NULL
evidence	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
has	NULL
a	NULL
fundamental	NULL
role	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
the	NULL
biochemical	NULL
signal	NULL
in	NULL
irradiated	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
that	NULL
leads	NULL
to	NULL
stimulation	NULL
of	NULL
multiple	NULL
serine-specific	NULL
protein	NULL
kinases	NULL
,	NULL
including	NULL
PKC	NULL
.	NULL

Role	NULL
of	NULL
Tyrosine	NULL
Phosphorylation	NULL
in	NULL
Radiation-Induced	NULL
Activation	NULL
of	NULL
in	NULL
Human	NULL
B-Lymphocyte	NULL
Precursors	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
an	NULL
inducible	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
regulation	NULL
of	NULL
a	NULL
series	NULL
of	NULL
target	NULL
genes	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Brach	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
ionizing	NULL
radiation	NULL
induces	NULL
expression	NULL
and	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
KG-1	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
by	NULL
a	NULL
PKC-dependent	NULL
mechanism	NULL
.	NULL

Furthermore	NULL
,	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
reported	NULL
that	NULL
diverse	NULL
agents	NULL
that	NULL
can	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
act	NULL
through	NULL
a	NULL
common	NULL
mechanism	NULL
involving	NULL
the	NULL
synthesis	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
utilized	NULL
electrophoretic	NULL
mobility-shift	NULL
assays	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
ionizing	NULL
radiation	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
B-lymphocyte	NULL
precursors	NULL
.	NULL

Notably	NULL
,	NULL
irradiation	NULL
with	NULL
10-40	NULL
Gy	NULL
of	NULL
y-rays	NULL
stimulated	NULL
a	NULL
NF-	NULL
«	NULL
B-specific	NULL
DNA-binding	NULL
activity	NULL
,	NULL
as	NULL
reflected	NULL
by	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
intensity	NULL
of	NULL
a	NULL
shifted	NULL
band	NULL
that	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Ramos	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
retarded	NULL
band	NULL
was	NULL
eliminated	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
500-fold	NULL
molar	NULL
excess	NULL
of	NULL
Medical	NULL
Sciences	NULL
:	NULL
Uckun	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
255	NULL
A	NULL
___	NULL
___	NULL
__________	NULL
Whole	NULL
Cell	NULL
Lysates	NULL
:	NULL
C_	NULL
a	NULL
y-rays	NULL
(	NULL
cGy	NULL
)	NULL
initrd	NULL
cs	NULL
oice	NULL
hort	NULL
,	NULL
al	NULL
3	NULL
e	NULL
cele	NULL
-	NULL
(	NULL
,	NULL
kpa	NULL
[	NULL
0	NULL
507100200	NULL
400	NULL
``	NULL
Herbimycin	NULL
+	NULL
va	NULL
y-rays	NULL
(	NULL
cGy	NULL
)	NULL
-rays	NULL
(	NULL
cGy	NULL
)	NULL
kpa	NULL
con	NULL
's0	NULL
100	NULL
200	NULL
400	NULL
``	NULL
``	NULL
so	NULL
100	NULL
200	NULL
400	NULL
'	NULL
®	NULL
B	NULL
Phosphoamino	NULL
Acid	NULL
Analysis	NULL
fous	NULL
$	NULL
>	NULL
n	NULL
0	NULL
®	NULL
78s	NULL
B	NULL
s	NULL
'	NULL
P	NULL
/	NULL
e	NULL
a	NULL
s	NULL
*	NULL
f	NULL
§	NULL
``	NULL
mm	NULL
)	NULL
:	NULL
_	NULL
{	NULL
®	NULL
t	NULL
@	NULL
°	NULL
T	NULL
ud	NULL
\	NULL
5	NULL
y	NULL
te-	NULL
y	NULL
sews	NULL
--	NULL
has	NULL
¥	NULL
PK76	NULL
PK55	NULL
PK50	NULL
KRA	NULL
D	NULL
REH	NULL
(	NULL
Pre-Pre-B	NULL
)	NULL
y-rays	NULL
(	NULL
cGy	NULL
y-rays	NULL
(	NULL
cGy	NULL
)	NULL
KC	NULL
___	NULL
10	NULL
25	NULL
50100200	NULL
.	NULL

pa	NULL
0	NULL
10	NULL
25	NULL
50	NULL
100	NULL
200	NULL
r	NULL
N	NULL
kD	NULL
%	NULL
T	NULL
6-	NULL
«	NULL
#	NULL
8	NULL
#	NULL
*	NULL
®	NULL
DAUDI	NULL
(	NULL
Early	NULL
B	NULL
)	NULL
PKC	NULL
Immunoprecipitates	NULL
UPN10	NULL
(	NULL
Pre-Pre-B	NULL
)	NULL
76	NULL
e	NULL
6	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

PTK-dependent	NULL
activation	NULL
of	NULL
PKC	NULL
and	NULL
PKC-dependent	NULL
renaturable	NULL
serine	NULL
kinases	NULL
in	NULL
irradiated	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
.	NULL

(	NULL
A	NULL
and	NULL
C	NULL
)	NULL
Ramos	NULL
early	NULL
B	NULL
cells	NULL
were	NULL
irradiated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
PTK	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
(	NULL
HERB	NULL
)	NULL
or	NULL
the	NULL
PKC	NULL
inhibitor	NULL
H7	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
15	NULL
min	NULL
after	NULL
irradiation	NULL
,	NULL
and	NULL
kinase	NULL
renaturation	NULL
assays	NULL
were	NULL
performed	NULL
(	NULL
10	NULL
)	NULL
with	NULL
whole	NULL
cell	NULL
lysates	NULL
(	NULL
A	NULL
)	NULL
or	NULL
immunoprecipitated	NULL
PKC	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Each	NULL
band	NULL
represents	NULL
P	NULL
covalently	NULL
bound	NULL
to	NULL
protein	NULL
and	NULL
corresponds	NULL
to	NULL
a	NULL
distinct	NULL
protein	NULL
kinase	NULL
.	NULL

A	NULL
shows	NULL
a	NULL
representative	NULL
experiment	NULL
in	NULL
which	NULL
ionizing	NULL
radiation	NULL
was	NULL
found	NULL
to	NULL
activate	NULL
multiple	NULL
serine-specific	NULL
protein	NULL
kinases	NULL
(	NULL
Leff	NULL
)	NULL
and	NULL
an	NULL
experiment	NULL
demonstrating	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
herbimycin	NULL
on	NULL
radiation-induced	NULL
activation	NULL
of	NULL
serine	NULL
kinases	NULL
(	NULL
Right	NULL
)	NULL
.	NULL

CON	NULL
,	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Phospho	NULL
amino	NULL
acid	NULL
analysis	NULL
of	NULL
the	NULL
kinase	NULL
bands	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Positions	NULL
of	NULL
phosphoserine	NULL
(	NULL
S	NULL
)	NULL
,	NULL
phosphothreonine	NULL
(	NULL
T	NULL
)	NULL
,	NULL
and	NULL
phosphotyrosine	NULL
(	NULL
Y	NULL
)	NULL
standards	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Kinase	NULL
renaturation	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
whole	NULL
cell	NULL
lysates	NULL
of	NULL
irradiated	NULL
REH	NULL
pre-pre-B	NULL
,	NULL
UPN	NULL
pre-pre-B	NULL
,	NULL
and	NULL
Daudi	NULL
early	NULL
B	NULL
cells	NULL
.	NULL

unlabeled	NULL
NF-KB	NULL
oligonucleotide	NULL
,	NULL
confirming	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
DNA-protein	NULL
interactions	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
a	NULL
500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-1	NULL
control	NULL
oligonucleotide	NULL
did	NULL
not	NULL
compete	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
retarded	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
extend	NULL
the	NULL
findings	NULL
of	NULL
Brach	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
on	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
and	NULL
provide	NULL
unambiguous	NULL
evidence	NULL
that	NULL
ionizing	NULL
radiation	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
radiation-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
Ramos	NULL
cells	NULL
were	NULL
treated	NULL
overnight	NULL
with	NULL
the	NULL
potent	NULL
PTK	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
prior	NULL
to	NULL
irradiation	NULL
.	NULL

Herbimycin	NULL
pretreatment	NULL
substantially	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
NF-kB	NULL
protein-DNA	NULL
complexes	NULL
in	NULL
extracts	NULL
from	NULL
irradiated	NULL
Ramos	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
does	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
ionizing	NULL
radiation	NULL
can	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
several	NULL
different	NULL
mechanisms	NULL
,	NULL
but	NULL
it	NULL
indicates	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
an	NULL
important	NULL
step	NULL
in	NULL
radiation-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
biochemical	NULL
nature	NULL
of	NULL
signaling	NULL
events	NULL
in	NULL
irradiated	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
.	NULL

This	NULL
report	NULL
clarifies	NULL
the	NULL
chronological	NULL
sequence	NULL
of	NULL
biochemical	NULL
events	NULL
that	NULL
follow	NULL
exposure	NULL
to	NULL
ionizing	NULL
radia-tion	NULL
.	NULL

In	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
,	NULL
ionizing	NULL
radiation	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
stimulation	NULL
of	NULL
as	NULL
yet	NULL
unidentified	NULL
PTKs	NULL
that	NULL
are	NULL
probably	NULL
sensitive	NULL
to	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
ionizing	NULL
radiation	NULL
triggers	NULL
PTK	NULL
s	NULL
is	NULL
unknown	NULL
.	NULL

Irradiation	NULL
subsequently	NULL
leads	NULL
to	NULL
(	NULL
i	NULL
)	NULL
stimulation	NULL
of	NULL
Ptdins	NULL
turnover	NULL
;	NULL
(	NULL
i	NULL
?	NULL
)	NULL

downstream	NULL
activation	NULL
by	NULL
covalent	NULL
modification	NULL
of	NULL
multiple	NULL
serine-specific	NULL
protein	NULL
kinases	NULL
,	NULL
including	NULL
PKC	NULL
;	NULL
and	NULL
(	NULL
ii	NULL
?	NULL
)	NULL

activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Our	NULL
study	NULL
of	NULL
radiation-induced	NULL
signaling	NULL
events	NULL
proximal	NULL
to	NULL
PKC	NULL
activation	NULL
has	NULL
linked	NULL
the	NULL
downstream	NULL
events	NULL
of	NULL
the	NULL
PKC	NULL
cascade	NULL
to	NULL
PTK-regulated	NULL
proximal	NULL
events	NULL
.	NULL

Further	NULL
,	NULL
this	NULL
report	NULL
confirms	NULL
previous	NULL
reports	NULL
by	NULL
Weichselbaum	NULL
and	NULL
colleagues	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
that	NULL
ionizing	NULL
radiation	NULL
can	NULL
activate	NULL
a	NULL
PKC-dependent	NULL
signaling	NULL
pathway	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

Since	NULL
both	NULL
PTK	NULL
and	NULL
PKC	NULL
or	NULL
PKC-dependent	NULL
kinases	NULL
256	NULL
Medical	NULL
Sciences	NULL
:	NULL
Uckun	NULL
et	NULL
al	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
PTK-dependent	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
in	NULL
irradiated	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
P-labeled	NULL
double-stranded	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
a	NULL
tandem	NULL
repeat	NULL
of	NULL
the	NULL
11-base-pair	NULL
consensus	NULL
sequence	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
site	NULL
.	NULL

Ramos	NULL
early	NULL
B	NULL
cells	NULL
were	NULL
irradiated	NULL
with	NULL
10-40	NULL
Gy	NULL
of	NULL
y-rays	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
PTK	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
2	NULL
hr	NULL
prior	NULL
to	NULL
extraction	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

Competition	NULL
studies	NULL
were	NULL
performed	NULL
by	NULL
preincubating	NULL
the	NULL
nuclear	NULL
protein	NULL
extracts	NULL
with	NULL
a	NULL
500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
competitor	NULL
(	NULL
Comp	NULL
.	NULL
)	NULL

prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
*°P-end-labeled	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
.	NULL

play	NULL
myriad	NULL
roles	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
function	NULL
and	NULL
proliferation	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
PTK-PKC	NULL
cascade	NULL
,	NULL
as	NULL
detailed	NULL
in	NULL
this	NULL
report	NULL
,	NULL
may	NULL
explain	NULL
the	NULL
pleiotropic	NULL
effects	NULL
of	NULL
ionizing	NULL
radiation	NULL
on	NULL
cellular	NULL
functions	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
Grant	NULL
R29	NULL
CA42111	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
.	NULL

F.M.U	NULL
.	NULL

is	NULL
a	NULL
Scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

This	NULL
is	NULL
publication	NULL
no	NULL
.	NULL

95	NULL
from	NULL
the	NULL
Tumor	NULL
Immunology	NULL
Laboratory	NULL
,	NULL
University	NULL
of	NULL
Minnesota	NULL
.	NULL

1	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Hallahan	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Weichselbaum	NULL
,	NULL
®	NULL
~a	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
R.	NULL
R.	NULL
&	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
5663-5666	NULL
.	NULL

Hallahan	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Viru-dachalam	NULL
,	NULL
S.	NULL
,	NULL
Kufe	NULL
,	NULL
D.	NULL
&	NULL
Weichselbaum	NULL
,	NULL
R.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
2156-2160	NULL
.	NULL

Uckun	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Dibirdik	NULL
,	NULL
I.	NULL
,	NULL
Smith	NULL
,	NULL
R.	NULL
,	NULL
Tuel-Ahigren	NULL
,	NULL
L.	NULL
,	NULL
Chandan-Langlie	NULL
,	NULL
M.	NULL
,	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Waddick	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
Hanson	NULL
,	NULL
M.	NULL
&	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
3589-3593.	NULL
,	NULL
Uckun	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Dibirdik	NULL
,	NULL
I.	NULL
,	NULL
Chandan-Langlie	NULL
,	NULL
M.	NULL
,	NULL
Tuel-Ahigren	NULL
,	NULL
L.	NULL
&	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
17478-17485	NULL
.	NULL

Uckun	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Tuel-Ahigren	NULL
,	NULL
L.	NULL
,	NULL
Song	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Waddick	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
Myers	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Kirihara	NULL
,	NULL
J.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
9005-9009	NULL
.	NULL

Hunter	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
249-270	NULL
.	NULL

Ullrich	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Schlessinger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
203-212	NULL
.	NULL

Uckun	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Mitchell	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Obuz	NULL
,	NULL
V.	NULL
,	NULL
Park	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Waddick	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
Friedman	NULL
,	NULL
N.	NULL
,	NULL
Oubaha	NULL
,	NULL
L.	NULL
,	NULL
Min	NULL
,	NULL
W.	NULL
S.	NULL
&	NULL
Song	NULL
,	NULL
C.	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Int	NULL
.	NULL

J.	NULL
Radiat	NULL
.	NULL

Oncol	NULL
.	NULL

Biol	NULL
.	NULL

Phys	NULL
.	NULL

21	NULL
,	NULL
1553-1560	NULL
.	NULL

Uckun	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Gillis	NULL
,	NULL
S.	NULL
,	NULL
Souza	NULL
,	NULL
L.	NULL
&	NULL
Song	NULL
,	NULL
C.	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Int	NULL
.	NULL

J.	NULL
Radiat	NULL
.	NULL

Oncol	NULL
.	NULL

Biol	NULL
.	NULL

Phys	NULL
.	NULL

16	NULL
,	NULL
415-435	NULL
.	NULL

Uckun	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Ramakrishnan	NULL
,	NULL
S.	NULL
&	NULL
Houston	NULL
,	NULL
L.	NULL
L.	NULL
(	NULL
1985	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

5	NULL
,	NULL
69-75	NULL
.	NULL

Ferrell	NULL
,	NULL
J.	NULL
E.	NULL
&	NULL
Martin	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
20723-20729	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
2336-2340	NULL
.	NULL

Singh	NULL
,	NULL
H.	NULL
,	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
&	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
319	NULL
,	NULL
154-158	NULL
.	NULL

Berridge	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

56	NULL
,	NULL
159-193	NULL
.	NULL

Ward	NULL
,	NULL
J.	NULL
F.	NULL
(	NULL
1988	NULL
)	NULL
Prog	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

35	NULL
,	NULL
95-125	NULL
.	NULL

Hutchinson	NULL
,	NULL
F.	NULL
(	NULL
1985	NULL
)	NULL
Prog	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

32	NULL
,	NULL
115-154	NULL
.	NULL

Di	NULL
Monte	NULL
,	NULL
D.	NULL
,	NULL
Belliomo	NULL
,	NULL
G.	NULL
,	NULL
Thor	NULL
,	NULL
H.	NULL
,	NULL
Nicotera	NULL
,	NULL
P.	NULL
&	NULL
Orrenius	NULL
,	NULL
S.	NULL
(	NULL
1984	NULL
)	NULL
Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

235	NULL
,	NULL
343-350	NULL
.	NULL

Nicotera	NULL
,	NULL
P.	NULL
,	NULL
Hartzell	NULL
,	NULL
P.	NULL
,	NULL
Baldi	NULL
,	NULL
C.	NULL
,	NULL
Svensson	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Bellomo	NULL
,	NULL
G.	NULL
&	NULL
Orrenius	NULL
,	NULL
S.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

261	NULL
,	NULL
14628-14635	NULL
.	NULL

Meisenfelder	NULL
,	NULL
J.	NULL
,	NULL
Suh	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Rhee	NULL
,	NULL
S.	NULL
G.	NULL
&	NULL
Hunter	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
1109-1122	NULL
.	NULL

Nishibe	NULL
,	NULL
S.	NULL
,	NULL
Wahl	NULL
,	NULL
M.	NULL
,	NULL
Rhee	NULL
,	NULL
S.	NULL
G.	NULL
&	NULL
Carpenter	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
10335-10338	NULL
.	NULL

Bageurle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
540-546	NULL
.	NULL

Brach	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Hass	NULL
,	NULL
R.	NULL
,	NULL
Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Gunji	NULL
,	NULL
H.	NULL
,	NULL
Weichselbaum	NULL
,	NULL
R.	NULL
&	NULL
Kufe	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
691-695	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P.	NULL
&	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2247-2258	NULL
.	NULL

